Similar Papers

Paper Title
Journal
Date
Author
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non–Small Cell Lung Cancer: A Predictive Marker of Efficacy?
Jordi Remon ... Benjamin Besse
Journal of Thoracic Oncology | VOL. 14
Jordi Remon, et. al.Jordi Remon ... Benjamin Besse
23 Apr 2019
Second-Line Chemotherapy for Non-small Cell Lung Cancer
John C Ruckdeschel
Chest | VOL. 129
John C RuckdeschelJohn C Ruckdeschel
01 Apr 2006
New Horizons in Chemotherapy: Platforms for Combinations in First-Line Advanced Non-small Cell Lung Cancer
Rogerio C Lilenbaum
Journal of Thoracic Oncology | VOL. 3
Rogerio C LilenbaumRogerio C Lilenbaum
01 Jun 2008
The Challenges of Third-Generation EGFR Tyrosine Kinase Inhibitors in the Therapy of Advanced NSCLC
Fen Wang ... Qing Zhou
Journal of Thoracic Oncology | VOL. 17
Fen Wang, et. al.Fen Wang ... Qing Zhou
17 Mar 2022
View more papers

More From: Strahlentherapie und Onkologie

Paper Title
Journal
Date
Author
Analysis of radiation oncology integration within general practitioners’ daily patient care: a cross-sectional survey in Germany
Sophia M Leiss ... Denise Bernhardt
Strahlentherapie und Onkologie | VOL. -
Sophia M Leiss, et. al.Sophia M Leiss ... Denise Bernhardt
16 Jan 2025
Gekommen, um zu bleiben? Nivolumab in der Erstlinientherapie des Hodgkin-Lymphoms im fortgeschrittenen Stadium – eine strahlentherapeutische Nachlese der SWOG-S1826-Studie
Michael Oertel ... Hans Theodor Eich
Strahlentherapie und Onkologie | VOL. -
Michael Oertel, et. al.Michael Oertel ... Hans Theodor Eich
03 Jan 2025
Friedrich Dessauer—reflections on his political and personal sacrifices
Michael Oertel ...
Strahlentherapie und Onkologie | VOL. 200
Michael Oertel, et. al.Michael Oertel ...
08 Nov 2024
Correction: Verbesserung der Ernährungssituation von Patienten mit fortgeschrittenem nicht-kleinzelligem Lungenkarzinom (NSCLC) durch Off-label-Medikation
Daphne Schepers-Von Ohlen
Strahlentherapie und Onkologie | VOL. 200
Daphne Schepers-Von OhlenDaphne Schepers-Von Ohlen
29 Oct 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.